Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.0900 (-18.37%)
At close: Nov 5, 2026
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $3.92 million as of November 5, 2026. It is the 45,752nd most valuable company in the world and the 6,075th biggest in the United States. Its market cap has decreased by 25.40% in one year.
Market Cap
3.92M
Enterprise Value
22.07M
Revenue
1.04M
Global Rank
Country Rank
#6,075 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 3.92M, an increase of 1,449.76%. That is a compound annual growth rate of 18.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 3.92M | 297.86% |
| Dec 31, 2025 | 985.22K | -89.92% |
| Dec 31, 2024 | 9.77M | -38.79% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 5.29M |
| OSR Health | 5.09M |
| Adaptimmune Therapeutics | 5.01M |
| Curative Biotechnology | 5.01M |
| Zenith Capital | 4.83M |
| Reviva Pharmaceuticals Holdings | 4.46M |
| LianMedical | 4.20M |
| BioAtla | 3.48M |